Gisele A Tavares

Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family.

Eric Vangrevelinghe, E. Vangrevelinghe, R. Falchetto, 2011, Journal of medicinal chemistry.

Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors.

Eric Vangrevelinghe, Clive McCarthy, Pascal Furet, 2010, Bioorganic & medicinal chemistry letters.